| Not Yet Recruiting | Non-invasive Ultrasound Retinal Stimulation for Vision Restoration NCT05914233 | University of Southern California | N/A |
| Not Yet Recruiting | A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) NCT07496567 | EyeBiotech Ltd. | Phase 2 / Phase 3 |
| Recruiting | A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) NCT07440225 | EyeBiotech Ltd. | Phase 2 / Phase 3 |
| Recruiting | Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal NCT07461441 | Yeungnam University College of Medicine | Phase 3 |
| Enrolling By Invitation | AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and Glaucoma NCT07318428 | Inje University | N/A |
| Not Yet Recruiting | High Resolution Imaging OCT Study NCT07338461 | Heidelberg Engineering GmbH | N/A |
| Not Yet Recruiting | User-centric Study of Patients' Receptiveness Towards the Web-based Automated Vision Impairment Gaze-tracking NCT07338513 | Tan Tock Seng Hospital | — |
| Recruiting | Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macul NCT07235527 | Saglik Bilimleri Universitesi | — |
| Recruiting | Effect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression NCT05465252 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | N/A |
| Recruiting | AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance NCT06619405 | Duke University | N/A |
| Recruiting | Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants NCT07160179 | AbbVie | Phase 1 / Phase 2 |
| Not Yet Recruiting | Preparation of Patient Autologous Induced Pluripotent Stem Cell-derived Retinal Cells for AMD NCT05991986 | Zhongshan Ophthalmic Center, Sun Yat-sen University | — |
| Recruiting | Identification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response to Vascular Endothel NCT07249216 | Singapore National Eye Centre | N/A |
| Recruiting | A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity NCT06961370 | Hoffmann-La Roche | Phase 1 |
| Recruiting | A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age- NCT06970665 | Astellas Pharma Inc | Phase 4 |
| Not Yet Recruiting | Strategies for Improving Linkage-to-Care After Eye Disease Screening NCT06943599 | University of California, San Francisco | N/A |
| Recruiting | The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration NCT06319872 | University of Rochester | Phase 1 |
| Recruiting | Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID) NCT06924021 | University of Wisconsin, Madison | — |
| Recruiting | Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration NCT06662162 | i-Lumen Scientific AUS PTY LTD | N/A |
| Recruiting | Effect of Video Viewing on Intravitreal Injection Experience NCT07002372 | Second Affiliated Hospital, School of Medicine, Zhejiang University | N/A |
| Not Yet Recruiting | An Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings NCT06918028 | Zhongshan Ophthalmic Center, Sun Yat-sen University | — |
| Recruiting | The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma NCT06593405 | MCPHS University | EARLY_Phase 1 |
| Recruiting | Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With NCT06351657 | Medical University of Vienna | — |
| Recruiting | Functional and Anatomical Visual Investigations in Patients With Early Forms of Age-related Macular Degenerati NCT06694272 | Fondation Ophtalmologique Adolphe de Rothschild | — |
| Recruiting | Visual Frailty in Ageing NCT06604104 | University of Edinburgh | — |
| Active Not Recruiting | A Phase I, Open-label, Multicenter, Dose-Escalating Study to Evaluate the Safety and Tolerability of KH658 Gen NCT06825858 | Chengdu Origen Biotechnology Co., Ltd. | Phase 1 |
| Not Yet Recruiting | Adjunct Episcleral Brachytherapy for PCV NCT05251636 | Salutaris Medical Devices, Inc. | Phase 3 |
| Recruiting | Personalised Monitoring of Early and Intermediate Age-related Macular Degeneration With Artificial Intelligenc NCT06351670 | Medical University of Vienna | — |
| Recruiting | Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies NCT06787482 | Ace Cells Lab Limited | Phase 1 / Phase 2 |
| Recruiting | Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD) NCT05803785 | Benobio Co., Ltd. | Phase 1 |
| Recruiting | Evaluation of Clinical Progression, Prognostic Factors, and Quality of Life in Patients with Age-related Macul NCT06899360 | University of Udine | — |
| Completed | Ocular Safety and Usability Study for FYB203 PFS NCT06708637 | Formycon AG | Phase 4 |
| Completed | Intravitreal Faricimab in Patients With Refractory Macular Edema NCT07093385 | University of Baghdad | Phase 2 |
| Not Yet Recruiting | Personalized Shared Eye-care Identification of Age-related Macular Degeneration Using Artificial Intelligence NCT06465212 | Medical University of Vienna | — |
| Recruiting | Safety and Tolerability of KH658 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (n NCT06458595 | Chengdu Origen Biotechnology Co., Ltd. | Phase 1 / Phase 2 |
| Completed | Robotic Subretinal tPA Injection Study NCT06347107 | Universitaire Ziekenhuizen KU Leuven | N/A |
| Enrolling By Invitation | Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - SUMMIT (Part 2) NCT06682455 | University of Southampton | — |
| Completed | Ocular Safety and Usability Study for FYB201 PFS NCT06708624 | Formycon AG | Phase 4 |
| Recruiting | Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Deg NCT06394232 | Eyestem Research Pvt. Ltd. | Phase 1 / Phase 2 |
| Not Yet Recruiting | Impact of Age-related Macular Degeneration on Daily Living Activitie NCT06333873 | Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | N/A |
| Recruiting | Developing and Testing a Model to Identify Preventive Vision Loss Among Older Patients in General Practice NCT07015034 | University of Copenhagen | N/A |
| Recruiting | Effects of Goji vs. Fiber on Macular Degeneration NCT06237127 | University of California, Davis | N/A |
| Active Not Recruiting | Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy NCT06164587 | Michelle Abou-Jaoude | Phase 1 / Phase 2 |
| Completed | Retinal Fundus Flavoprotein Fluorescence in Age Related Macular Degeneration NCT06381596 | University of Wisconsin, Madison | N/A |
| Active Not Recruiting | Retinal Pigment Epithelium Safety Study for Patients in B4711001 NCT03102138 | Moorfields Eye Hospital NHS Foundation Trust | — |
| Recruiting | Multicenter Real-life Observational Study Switched Aflibercept or Ranibizumab to Faricimab in Patients With AM NCT06271330 | Nantes University Hospital | — |
| Unknown | Evaluation of Therapeutic Efficacy of Faricimab for Clinical AMD, DME, and RVO Patients NCT06572553 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 2 / Phase 3 |
| Recruiting | Lutein, Zeaxathin, and Fish Oil Supplementation NCT06489873 | Texas A&M University | N/A |
| Unknown | Efficacy of Laser Acupuncture on Zanzhu (BL02) for Dry Age-related Macular Degeneration NCT06264947 | China Medical University Hospital | N/A |
| Completed | A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects with Neovascular Age-related Ma NCT06190093 | Outlook Therapeutics, Inc. | Phase 3 |
| Unknown | Vision Improvement for Patients With Age-Related Macular Degeneration NCT04268836 | Optimal Acuity Corporation | N/A |
| Completed | Change in Ocular Perfusion After Intravitreal Anti-VEGF in Patients with Age-related Maculopathy or Diabetic M NCT06878573 | Augenabteilung Allgemeines Krankenhaus Linz | — |
| Recruiting | Progression of Early Atrophic Lesions NCT05959005 | University of Utah | — |
| Active Not Recruiting | Safety and Tolerability of KH631 Gene Therapy in Participants With Neovascular Age-related Macular Degeneratio NCT05657301 | Chengdu Origen Biotechnology Co., Ltd. | Phase 1 |
| Active Not Recruiting | Ocular, Vascular, and Genetic Findings in AMD Patients NCT06015633 | OcuDyne, Inc. | — |
| Unknown | Evaluation of New Head-mounted Visual Aids Among Patients With Low Vision NCT06076720 | Zhongshan Ophthalmic Center, Sun Yat-sen University | N/A |
| Completed | Preventive TREatment of Dry Eye in Patients Receiving Repeated Intravitreal Injections for Age-related Macular NCT06174181 | Direction Centrale du Service de Santé des Armées | N/A |
| Active Not Recruiting | NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration NCT05984927 | Elisigen, Inc. | Phase 1 / Phase 2 |
| Active Not Recruiting | A Snapshot Adaptive Optics and Hyperspectral Autofluorescence Fundus Camera for Age-Related Macular Degenerati NCT03963817 | Icahn School of Medicine at Mount Sinai | — |
| Unknown | A Study of the SING IMT in an Israeli Cohort NCT05941273 | VisionCare, Inc. | N/A |
| Unknown | OphtAI Diagnostic Performance Validation for Automated Screening of Eye Diseases NCT05752045 | Evolucare Technologies | N/A |
| Recruiting | Direct Discrimination of Quantum States by the Human Eye NCT05913063 | Centre for Eye and Vision Research | N/A |
| Recruiting | Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration NCT06087458 | Perceive Biotherapeutics, Inc. | Phase 1 / Phase 2 |
| Terminated | Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondar NCT05893537 | Cognition Therapeutics | Phase 2 |
| Active Not Recruiting | A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Stud NCT05698316 | Association for Innovation and Biomedical Research on Light and Image | — |
| Recruiting | Expressive Arts-based Intervention for Adults With Age-related Visual Impairment NCT05675150 | The University of Hong Kong | N/A |
| Active Not Recruiting | Automated Vision Assessment and Impairment Detection Through Gaze Analysis in Wet AMD Patients NCT06518512 | Tan Tock Seng Hospital | — |
| Recruiting | Photobiomodulation in Dry Age Related Macular Degeneration NCT06046118 | Azienda Ospedaliera Universitaria Mater Domini, Catanzaro | N/A |
| Terminated | Comfortable and Stabilizing Chin & Forehead Rest Attachment for Slit Lamp Configurations NCT05686421 | NYU Langone Health | N/A |
| Unknown | Patient-centred Smartphone AI for Protecting Vision in Macular Disease NCT05433766 | OKKO Health | — |
| Completed | Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images NCT06213896 | Ural Telekomunikasyon Sanayi Ticaret Anonim Sirketi | — |
| Completed | OcuDyne System in the Treatment of AMD NCT05091476 | OcuDyne, Inc. | N/A |
| Recruiting | Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (n NCT05672121 | Chengdu Origen Biotechnology Co., Ltd. | Phase 1 / Phase 2 |
| Active Not Recruiting | Impact of Non-Exudative Type 1 MNV on AMD Progression NCT06125977 | University of Utah | — |
| Unknown | Prospective triAl of Modified Treat-and-extend Regimens With BroLucizumab in pachychOroid Neovasculopathy NCT05672979 | Yeungnam University College of Medicine | Phase 3 |
| Not Yet Recruiting | Retinal Care Data Repository NCT04794907 | Retinal Care Inc. | — |
| Completed | The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain NCT05542381 | Virginia Polytechnic Institute and State University | N/A |
| Completed | Validation of Bulbicam for DR- and AMD-patients NCT05441072 | Meddoc | — |
| Active Not Recruiting | ForeseeHome NRich Registry NCT05690880 | Notal Vision Inc. | — |
| Completed | Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV NCT05662943 | Kim's Eye Hospital | — |
| Not Yet Recruiting | Photobiomodulation for Dry Age Related Macula Degeneration NCT05507840 | Oslo University Hospital | N/A |
| Active Not Recruiting | Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration NCT05380492 | Perceive Biotherapeutics, Inc. | Phase 1 / Phase 2 |
| Unknown | OKKO Health Hyperacuity, Contrast and Colour Game Validation in Age-related Macular Degeneration NCT05569226 | OKKO Health | — |
| Completed | Targeted Fluorescence Imaging in AMD NCT05262244 | University Medical Center Groningen | Phase 1 |
| Unknown | Virtual Reality Based Vision Test in Patients With AMD NCT06241625 | Augenklinik Zurich West | N/A |
| Unknown | Molecular Imaging Exploration of Ocular Angiogenic Activity and Evaluation of Its Interest in the Therapeutic NCT04005443 | Assistance Publique Hopitaux De Marseille | N/A |
| Completed | Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy NCT05536297 | Astellas Pharma Global Development, Inc. | Phase 3 |
| Recruiting | Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-r NCT04796545 | VisionCare, Inc. | N/A |
| Unknown | A Study to Investigate the Effect on Central Macular Thickness of Treatment With MG-O-1002 Eye Drops in Partic NCT05390840 | Theratocular Biotek Co. | Phase 2 |
| Completed | The Moran AMD Genetic Testing Assessment Study NCT05265624 | Paul S. Bernstein | Phase 2 |
| Completed | Treatment of Recalcitrant Neovascular AMD Using Brolocizumab With Immediate T&E NCT05710471 | The University of Hong Kong | Phase 4 |
| Recruiting | Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD NCT05438732 | VisionCare, Inc. | N/A |
| Recruiting | Survival of Monocytes Collected From Patients With Atrophic AMD in Retinal Pigmented Epithelium Explants NCT04697095 | Hospices Civils de Lyon | N/A |
| Active Not Recruiting | An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration NCT05300724 | Genentech, Inc. | — |
| Active Not Recruiting | Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals NCT05763940 | Western University of Health Sciences | N/A |
| Completed | Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT) NCT05447650 | i-Lumen Scientific, Inc. | N/A |
| Completed | Device for Age-related Macular Degeneration (AMD) NCT06178978 | University of Michigan | — |
| Unknown | Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells NCT05187104 | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Phase 1 / Phase 2 |
| Unknown | Therapy of Age-related Macular Degeneration NCT05222997 | Robert Hörantner | — |
| Active Not Recruiting | A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration NCT05230537 | Novartis Pharmaceuticals | Phase 2 |
| Recruiting | Visual Remapping to Aid Reading With Field Loss NCT03848663 | University of Minnesota | N/A |
| Unknown | Impact of Regular Consumption of Grapes on Eye Health in Singapore Older Adults NCT05064865 | National University of Singapore | N/A |
| Completed | Early Feasibility Study Using IOPCL MAG to Improve Near Vision in ARMD Subjects NCT04984590 | OnPoint Vision Inc | — |
| Terminated | Subthreshold Laser Treatment in Intermediate Age-related Macular Degeneration With Nascent Geographic Atrophy NCT05200624 | Center for Eye Research Australia | N/A |
| Active Not Recruiting | A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual I NCT05112861 | Outlook Therapeutics, Inc. | Phase 3 |
| Completed | Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD NCT05003245 | Shanghai Henlius Biotech | Phase 3 |
| Recruiting | Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Init NCT05635266 | Sanguine Biosciences | — |
| Completed | A Virtual Reality Platform Simulating Visual Impairment for Testing of Electronic Travel Aids and Performing O NCT05135195 | NYU Langone Health | N/A |
| Completed | A Study of Implantation of Retinal Pigment Epithelium in Subjects with Acute Wet Age Related Macular Degenerat NCT01691261 | Moorfields Eye Hospital NHS Foundation Trust | Phase 1 |
| Completed | Effectiveness of Prism Spectacles in Patients With Age Related Macular Degeneration NCT05437302 | University of Faisalabad | N/A |
| Completed | A Study to Evaluate the Safety and Efficacy of RQC for AMD NCT05062486 | Paul A Knepper, MD PhD | Phase 2 |
| Completed | Observational Study of Vision Improvement in Patients With Retinal Disorders NCT04693702 | Optimal Acuity Corporation | — |
| Completed | MP-3 Biofeedback Training and Central Vision Loss NCT05772780 | Amore Filippo | N/A |
| Recruiting | Adaptive Optics Imaging of Outer Retinal Diseases NCT05355415 | Food and Drug Administration (FDA) | — |
| Completed | Adherence to Lifestyle Changes for Age-related Macular Degeneration NCT05667441 | Erasmus Medical Center | N/A |
| Unknown | Possible Effects of Supplement Therapy With Oral Phenolics on Cluster of Differentiation 163 (CD-163) Biomarke NCT05005884 | Shahid Beheshti University of Medical Sciences | Phase 1 |
| Completed | Evaluate the Safety and Efficacy of HLX04-O in Subjects With wAMD NCT04993352 | Shanghai Henlius Biotech | Phase 1 / Phase 2 |
| Completed | Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Dege NCT04679935 | Novartis Pharmaceuticals | Phase 4 |
| Completed | A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD NCT04740671 | Shanghai Henlius Biotech | Phase 3 |
| Completed | RBM-007 in Treatment naïve Exudative Age-related Macular Degeneration NCT04895293 | Maturi, Raj K., M.D., P.C. | Phase 1 / Phase 2 |
| Completed | Metabolomics: A Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration NCT04241536 | Association for Innovation and Biomedical Research on Light and Image | N/A |
| Completed | QA102 Phase 1 Study in Healthy Young and Older Adult Subjects NCT04894071 | Smilebiotek Zhuhai Limited | Phase 1 |
| Completed | Analysis of naïve Patients With Age-related Macular Degeneration of the Neovascular Type and Treated With Afli NCT04891835 | Laurence Postelmans | — |
| Completed | Assessing the Quality of Life and Social Support in Age-Related Macular Degeneration Patients NCT05427994 | Asfendiyarov Kazakh National Medical University | — |
| Completed | Visual Outcome After Vitrectomy With Subretinal tPA Injection NCT05196139 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients With Geographic Atrophy Study NCT05963646 | Institute of Molecular and Clinical Ophthalmology Basel | — |
| Completed | Effect of Micronutrient Supplementation on the Intestinal Microbiota in Patients With Age-related Macular Dege NCT06391411 | Azienda Ospedaliero-Universitaria Careggi | N/A |
| Completed | The Effect of Ocular Rinse Volume on Surface Irritation After Intravitreal Injections NCT05615805 | University of Oklahoma | N/A |
| Completed | Visual Function Change in Wet Age-related Macular Degeneration Patients With Better Baseline Visual Acuity NCT06330220 | Seoul National University Hospital | Phase 4 |
| Recruiting | Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD NCT04735263 | Massachusetts Eye and Ear Infirmary | Phase 2 |
| Recruiting | Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression NCT04739319 | Center for Eye Research Australia | — |
| Completed | Macula Evolution in Patients With AMD Taking Oral Food Supplementation NCT04778436 | Laboratoires Thea | N/A |
| Unknown | Oral Postbiotics in Patients With Macular Atrophy NCT05391074 | Institut de la Macula y la Retina | N/A |
| Unknown | Beovu Experience UZ Leuven NCT05220085 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | Ocular Coherence Tomography During Cataract Assessment NCT05287269 | Brighton and Sussex University Hospitals NHS Trust | — |
| Unknown | A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD） NCT04572698 | Luye Pharma Group Ltd. | Phase 3 |
| Completed | Effect of Oral Curcumin Supplementation in Dry Age-related Macular Degeneration (AMD) Patients NCT04590196 | University of Illinois at Chicago | EARLY_Phase 1 |
| Completed | A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders NCT04516278 | Outlook Therapeutics, Inc. | Phase 3 |
| Completed | Association of MPOD Values With Blue Light. NCT04779398 | The University of Queensland | — |
| Unknown | Eye Movement Rehabilitation in Low Vision Patients NCT04929756 | Northeastern University | — |
| Completed | Study of Photobiomodulation Effect on Electroretinogram Outcomes in Dry Age-Related Macular Degeneration NCT04522999 | LumiThera, Inc. | N/A |
| Completed | Online Validation of Dietary Intake Food Frequency Questionnaire Over Four Weeks, and Electronic Device Use Qu NCT04779411 | The University of Queensland | — |
| Completed | A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) NCT04486963 | Tasly Pharmaceutical Group Co., Ltd | Phase 2 |
| Unknown | Telemedicine in Age-Related Macular Degeneration NCT04863391 | The New York Eye & Ear Infirmary | — |
| Completed | Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) o NCT04395859 | Fondation Ophtalmologique Adolphe de Rothschild | — |
| Withdrawn | Mitochondrial DNA in Vitreous Fluid and Blood in Patients With Eye Disease or Ocular Trauma. NCT04334499 | The University of Texas Medical Branch, Galveston | — |
| Completed | Study of the Discriminating Power of a Blood Biomarker for Omega-3 Polyunsaturated Fatty Acid Content of the R NCT04278300 | Centre Hospitalier Universitaire Dijon | — |
| Unknown | Analysis of the Intestinal Microbiome in Patients With Wet Age-related Macular Degeneration NCT05757674 | University of Ioannina | — |
| Completed | Study Evaluating Retinal Health Monitoring System Visual Acuity Module. NCT04169802 | Kubota Vision Inc. | — |
| Active Not Recruiting | Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - PINNACLE NCT04269304 | University of Southampton | — |
| Unknown | Computer-based Tutorial and Automated Speech Recognition for Intravitreal Drug Injections NCT04142164 | Prim. Prof. Dr. Oliver Findl, MBA | N/A |
| Completed | Functionally Validated Structural Endpoints for Early AMD NCT04112667 | Cynthia Owsley | — |
| Completed | Efficacy and Safety of Aflibercept in Patients With Neovascular Age-related Macular Degeneration NCT05587062 | Cinnagen | Phase 3 |
| Unknown | Biomarkers of Common Eye Diseases NCT04101604 | Sun Yat-sen University | — |
| Completed | Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control NCT04005352 | Novartis Pharmaceuticals | Phase 3 |
| Withdrawn | A Safety and Efficacy Study of Carbidopa-levodopa in Patients With Macular Degeneration NCT02873351 | Snyder, Robert W., M.D., Ph.D., P.C. | Phase 2 |
| Completed | OCTA and Retinal Angiomatous Proliferation NCT04689789 | Federico II University | — |
| Completed | Eyes That Do Not Meet the Eligibility Criteria of Clinical Trials on Age-Related Macular Degeneration: Proport NCT04836143 | Kim's Eye Hospital | — |
| Unknown | Age-related Macular Degeneration (AMD) and Cardiovascular Disease NCT04087356 | The New York Eye & Ear Infirmary | — |
| Completed | Optimising Visual Acuity Measurement in Macular Degeneration NCT04920071 | Moorfields Eye Hospital NHS Foundation Trust | — |
| Completed | Povidone Iodine vs AVEnova: A Pre-injection Disinfection Study (PAVE Study) NCT04018482 | California Retina Consultants | Phase 4 |
| Unknown | Evaluation of the Performance of Self-monitoring Optimized by Therapeutic Education in the Recurrence of Wet A NCT04032808 | Clinique Beau Soleil | — |
| Completed | A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age- NCT03834753 | Outlook Therapeutics, Inc. | Phase 3 |
| Completed | Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD NCT03954626 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Implantation of SML in Patients With Dry Age-related Macular Degeneration and Myopic Maculopathy NCT03882606 | Consorci Sanitari de Terrassa | N/A |
| Completed | Phase 2/3 Study of ALK-001 in Geographic Atrophy NCT03845582 | Alkeus Pharmaceuticals, Inc. | Phase 2 / Phase 3 |
| Terminated | Global Atrophie Biomarker Evaluation Study (GABiE) NCT03935126 | Boehringer Ingelheim | — |
| Unknown | Imaging of the Angiofibrotic Switch in Neovascular AMD NCT03838679 | Medical University of Vienna | — |
| Recruiting | Village-Integrated Eye Worker Trial II NCT03752840 | University of California, San Francisco | N/A |
| Completed | Association Between Age-related Macular Degeneration and Cognitive Impairment Based on Exosome Proteomics NCT06883461 | Shanghai 10th People's Hospital | — |
| Completed | ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-c NCT03891875 | Stealth BioTherapeutics Inc. | Phase 2 |
| Terminated | A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macul NCT03869684 | Senju Pharmaceutical Co., Ltd. | Phase 2 |
| Unknown | Assessment of Visual Function With a Portable Brain-computer Interface NCT03760055 | NGoggle | — |
| Unknown | Effect of Corona Virus on Intravitreal Injections NCT05494775 | Benha University | N/A |
| Completed | Removal of Massive Subretinal Organized Blood Clot With Fragmatome NCT04196049 | Changhua Christian Hospital | — |
| Recruiting | Intermediate Age-related Macular Degeneration - Multimodal Analysis and Longitudinal Study NCT06355830 | Universidade Nova de Lisboa | — |
| Completed | Surgical Outcome of Macular Membrane Peeling Associated With Significant Macular Drusen NCT03927430 | Klinikum Chemnitz gGmbH | — |
| Unknown | Stem Cells Therapy in Degenerative Diseases of the Retina NCT03772938 | Pomeranian Medical University Szczecin | Phase 1 |
| Completed | Evaluation of the Safety and Efficacy of ALS-L1023 Administered in Combination With Ranibizumab in Patients Wi NCT03725501 | AngioLab, Inc. | Phase 2 |
| Unknown | PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLibercept NCT02681783 | Sunnybrook Health Sciences Centre | Phase 4 |
| Completed | Assay of Pro-angiogenic Cytokines in Exudative Age-Related Macular Degeneration NCT03630562 | Centre Hospitalier Universitaire de Nice | N/A |
| Unknown | Safety and Tolerability of Oral CM082 in Patients With wAMD NCT03710863 | AnewPharma | Phase 2 |
| Terminated | Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every NCT03710564 | Novartis Pharmaceuticals | Phase 3 |
| Completed | A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular Degeneration NCT04151212 | Bio-Thera Solutions | Phase 1 |
| Completed | A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age- NCT03844074 | Outlook Therapeutics, Inc. | Phase 3 |
| Unknown | Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Beva NCT03609307 | Shahid Beheshti University of Medical Sciences | Phase 2 / Phase 3 |
| Completed | Age-Related Macular Degeneration, Scotopic Dysfunction, and Driving Performance in a Simulator NCT03166202 | University of Alabama at Birmingham | — |
| Completed | RBM-007 in Subjects witH ExudatIve Age-related Macular Degeneration NCT03633084 | Ribomic USA Inc | Phase 1 / Phase 2 |
| Recruiting | A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central V NCT03178149 | Astellas Institute for Regenerative Medicine | Phase 1 |
| Terminated | Carbidopa-Levodopa in Dry AMD With Geographic Atrophy NCT03451500 | Snyder, Robert W., M.D., Ph.D., P.C. | Phase 2 |
| Completed | FLIO and the Influence of Oral Lutein Supplementation on Macular Pigment NCT04761341 | Insel Gruppe AG, University Hospital Bern | Phase 4 |
| Unknown | Automatic Self Transcending Meditation (ASTM) for Patients With Severe Age Related Macular Degeneration (AMD) NCT03104608 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | N/A |
| Completed | Village-Integrated Eye Worker Trial II - Pilot NCT03278587 | University of California, San Francisco | N/A |
| Completed | Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation NCT03478878 | National Eye Institute (NEI) | EARLY_Phase 1 |
| Unknown | Comfort and Antimicrobial Efficacy of Chlorhexidine vs Betadine for Intravitreal Injections NCT03571100 | MidAtlantic Retina | EARLY_Phase 1 |
| Completed | Comparison of Complement Factors and Genetic Polymorphisms of AMD Between Patients With Systemic Lupus Erythem NCT03504540 | Fondation Ophtalmologique Adolphe de Rothschild | — |
| Completed | Triamcinolone Acetonide in Patients With Serous Pigment Epithelial Detachment NCT04292756 | The Filatov Institute of Eye Diseases and Tissue Therapy | N/A |
| Withdrawn | Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary NCT03446144 | Ionis Pharmaceuticals, Inc. | Phase 2 |
| Completed | A Study to Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related NCT03150589 | Samsung Bioepis Co., Ltd. | Phase 3 |
| Unknown | Multimodal Retinal Imaging in the Detection and Follow-up of Alzheimer's Disease NCT03466177 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | AMD Ryan Initiative Study (ARIS) NCT03092492 | National Eye Institute (NEI) | — |
| Completed | Evaluation of a New Eye-specific Multivitamin Formula in Participants at Risk of Age-related Macular Degenerat NCT03946085 | Guardion Health Sciences, Inc. | N/A |
| Completed | Prevalence of Age Related Macular Degeneration (ARMD) in Parkinson's Patients and Assesment of the Role of L-D NCT03415984 | Fondation Ophtalmologique Adolphe de Rothschild | — |
| Unknown | Reading Analysis in Ophthalmologic Patients NCT03750149 | Prim. Prof. Dr. Oliver Findl, MBA | N/A |
| Completed | An Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy NCT03117634 | Singapore National Eye Centre | Phase 4 |
| Unknown | Polarization Perception in Health and Disease. Testing a New Sight Test NCT03823092 | South Warwickshire NHS Foundation Trust | — |
| Completed | Recurrent Neovascular Age-related Macular Degeneration After Therapy Suspension NCT04659512 | St. Erik Eye Hospital | — |
| Terminated | Visual Function Tests in Age-related Macular Degeneration NCT03275753 | ORA, Inc. | — |
| Completed | Evaluate the Quality of Life of Patients With AMD NCT03242083 | Centre Hospitalier Universitaire Dijon | — |
| Completed | Study Assessing the Efficacy and Safety of Intravitreal Injections of DE-122 in Combination With Lucentis® Com NCT03211234 | Santen Inc. | Phase 2 |
| Active Not Recruiting | Dark Adaptation in Participants With Age-Related Macular Degeneration NCT03225131 | National Eye Institute (NEI) | — |
| Terminated | Words on the Brain: Can Reading Rehabilitation for Age-Related Vision Impairment Improve Cognitive Functioning NCT04276610 | Université de Montréal | N/A |
| Completed | Dose Ranging Study of Carbidopa-levodopa NCT03023059 | Snyder, Robert W., M.D., Ph.D., P.C. | Phase 2 |
| Completed | Carbidopa-levodopa in Neovascular AMD NCT03022318 | Snyder, Robert W., M.D., Ph.D., P.C. | Phase 2 |
| Completed | Omega 3 and Vitamin D Dosage in a Population With Moderate to High Risk of AMD NCT04482465 | Universitaire Ziekenhuizen KU Leuven | N/A |
| Unknown | Telescope Exchange Study NCT03011554 | VisionCare, Inc. | N/A |
| Completed | Patient's Feelings After Receiving a Diagnosis of Age-related Macular Degeneration NCT03035461 | Centre Hospitalier Intercommunal Creteil | — |
| Completed | Macular Thickness Measurements Using Retinal-thickness OCT NCT03030729 | Notal Vision Ltd. | — |
| Completed | Natural History of Geographic Atrophy Associated With Age-Related Macular Degeneration NCT02941263 | National Eye Institute (NEI) | — |
| Unknown | Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab NCT03056092 | Unity Health Toronto | Phase 4 |
| Unknown | Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases NCT03128463 | Xun Xu | — |
| Unknown | Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept NCT03056079 | Unity Health Toronto | Phase 4 |
| Completed | Safety and Clinical Effectiveness of Intravitreal Bevacizumab (Lumiere®) in Patients With Wet Age-related Macu NCT03668054 | Laboratorio Elea Phoenix S.A. | Phase 3 |
| Completed | 30g vs 33g Needle for Intravitreal Injections NCT03038048 | Wills Eye | N/A |
| Completed | Retinal Imaging Using NOTAL-OCT NCT03374020 | Notal Vision Ltd. | — |
| Completed | Effect of Aflibercept on Human Corneal Endothelial Cells in Neovascular Age-Related Macular Degeneration NCT03313401 | Ulucanlar Eye Training and Research Hospital | — |
| Completed | Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated With Age-Related Macular Dege NCT02564978 | National Eye Institute (NEI) | Phase 2 |
| Completed | An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in NCT02848313 | Stealth BioTherapeutics Inc. | Phase 1 |
| Completed | The Impact of Two Strategies in the Monitoring of Exudative ARMD on the Visual Acuity (by OCT B Scan or OCT An NCT02868086 | Fondation Ophtalmologique Adolphe de Rothschild | N/A |
| Completed | Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections NCT02951351 | Mayo Clinic | N/A |
| Completed | Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degenerati NCT02914639 | OcuTerra Therapeutics, Inc. | Phase 1 / Phase 2 |
| Unknown | Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular De NCT02802657 | Xiaodong Sun | Phase 4 |
| Unknown | Comparison of PDT Combination With Ranibizumab vs. Ranibizumab Monotherapy in Persistent PCV With Initial Load NCT02864472 | Seoul National University Hospital | Phase 4 |
| Completed | Flicker Fusion Thresholds Between Young and Old Subjects at Various Luminance Levels NCT03079570 | ORA, Inc. | — |
| Completed | Five-year Incidence of Age-related Macular Degeneration in the Central Region of Portugal NCT02748824 | Association for Innovation and Biomedical Research on Light and Image | — |
| Unknown | A Comparison of the Checkup Vision Assessment System to Standard Vision Assessment Tools NCT02871817 | Digisight Technologies, Inc. | — |
| Completed | Subthreshold Laser Treatment for Reticular Pseudodrusen and Geographic Atrophy Secondary to AMD NCT02800356 | Ospedale San Raffaele | N/A |
| Completed | Cytokeratin 8 Level in Age-related Macular Degeneration NCT02707575 | Gangnam Severance Hospital | — |
| Terminated | A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Adminis NCT02387957 | Ophthotech Corporation | Phase 2 |
| Unknown | Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD NCT02727881 | Ohr Pharmaceutical Inc. | Phase 3 |
| Completed | Head Mounted Eye Tracking Aide for Loss of Central Vision (HETALCEV) NCT02829606 | University of Minnesota | N/A |
| Completed | Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD NCT02684578 | University of California, San Francisco | Phase 2 |
| Completed | Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration NCT02725762 | LumiThera, Inc. | N/A |
| Completed | Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of NCT03024424 | University of Utah | N/A |
| Unknown | Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells Transplantation NCT02868424 | The First Affiliated Hospital with Nanjing Medical University | EARLY_Phase 1 |
| Completed | Head to Head Study of Anti-VEGF Treatment. NCT02577107 | Novartis Pharmaceuticals | Phase 4 |
| Recruiting | Stem Cell Ophthalmology Treatment Study II NCT03011541 | MD Stem Cells | N/A |
| Unknown | "Stop Early Age-related Macular Degeneration (AMD) From Vision Loss Eternally" Study NCT02960828 | Seoul National University Bundang Hospital | N/A |
| Completed | Comparison of Treatment rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen NCT02550002 | Insel Gruppe AG, University Hospital Bern | — |
| Recruiting | Aflibercept in Recurrent or Persistent CNV NCT02669953 | Medical University of Vienna | — |
| Completed | Alpha Lipoic Acid in Geographic Atrophy NCT02613572 | University of Pennsylvania | Phase 1 / Phase 2 |
| Unknown | Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD NCT02599064 | RXi Pharmaceuticals, Corp. | Phase 1 / Phase 2 |
| Unknown | Non-invasive Optical Angiography in Age-related Macular Degeneration NCT02521142 | Medical University of Vienna | — |
| Terminated | Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comté NCT02626377 | Centre Hospitalier Universitaire de Besancon | N/A |
| Completed | Development of Core Outcomes for Age-related Macular Degeneration (AMD) Interventions- Caregivers' Perspective NCT02567604 | Queen's University, Belfast | — |
| Completed | A Phase I/II Safety, Tolerability, Immunogenicity, and Bioactivity Study of DE-122 Injectable Solution for Ref NCT02555306 | Santen Inc. | Phase 1 / Phase 2 |
| Completed | Visual Activity Evoked by Infrared in Humans After Dark Adaptation NCT02909985 | University of New Mexico | N/A |
| Withdrawn | Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD NCT02563782 | Astellas Institute for Regenerative Medicine | Phase 2 |
| Terminated | Resveratrol for Exudative Age-Related Macular Degeneration NCT02625376 | Poitiers University Hospital | N/A |
| Completed | Stem Cell Therapy for Outer Retinal Degenerations NCT02903576 | Federal University of São Paulo | Phase 1 / Phase 2 |
| Completed | Cohort Study on the Age-related Macular Degeneration: Incidence and Research for Predisposing Factors NCT01918553 | University Hospital, Bordeaux | N/A |
| Completed | The Potential Role of Dietary Antioxidant Capacity on Age-Related Macular Degeneration NCT03326401 | Hacettepe University | — |
| Terminated | SD-OCT Angiography NCT02510885 | Duke University | N/A |
| Withdrawn | Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degene NCT02511613 | Ohr Pharmaceutical Inc. | Phase 2 |
| Completed | Multimodal Imaging of Retinal Vessels NCT02717026 | Medical University of Graz | — |
| Completed | IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD NCT02462889 | Jeffrey S Heier | Phase 2 |
| Completed | Argus II Retinal Prosthesis System Dry AMD Feasibility Study Protocol NCT02227498 | Second Sight Medical Products | N/A |
| Terminated | Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD NCT02467634 | StemCells, Inc. | Phase 2 |
| Unknown | Cataract and AMD in a Trial of a Multivitamin and Cocoa Extract NCT03205202 | Brigham and Women's Hospital | Phase 4 |
| Completed | Prophylactic Ranibizumab for Exudative Age-Related Macular Degeneration NCT02302989 | Leonard Feiner, MD, PhD | Phase 1 / Phase 2 |
| Terminated | Study of WA-NG (NG-IMT) Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration NCT04468373 | VisionCare, Inc. | N/A |
| Completed | Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macul NCT02140411 | Novartis Pharmaceuticals | Phase 4 |
| Enrolling By Invitation | Smartphone Screening for Eye Diseases NCT03076697 | University of Michigan | — |
| Active Not Recruiting | Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration NCT02286089 | Hoffmann-La Roche | Phase 1 / Phase 2 |
| Completed | Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration NCT02422160 | Stanford University | — |
| Unknown | The Role of Inflammation in AMD and Related Disorders NCT02588378 | Unity Health Toronto | — |
| Completed | A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration NCT02401945 | Santen Inc. | Phase 2 |
| Completed | Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD NCT02357342 | Maturi, Raj K., M.D., P.C. | Phase 2 |
| Suspended | Phase 1 Study of CM082 in Patients With wAMD NCT02452385 | AnewPharma | Phase 1 |
| Unknown | The Role of Complement Factor H Polymorphism in the Regulation of Choroidal Vascular Tone in Young Healthy Sub NCT02102880 | Medical University of Vienna | N/A |
| Completed | The Focal Electro-Oculogram in Macular Disease NCT02225119 | National Eye Institute (NEI) | — |
| Completed | Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME. NCT02571972 | Wills Eye | Phase 2 |
| Completed | Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related NCT02358889 | Iconic Therapeutics, Inc. | Phase 2 |
| Completed | Evaluating the Relationship Between Function and Structure in ARCHER II-like Population Using Data From a Natu NCT07424235 | IRCCS Ospedale San Raffaele | — |
| Withdrawn | Risk Factors for Drusen Progression NCT01830608 | Medical University of Vienna | — |
| Completed | Evaluation of the Distortion Correction Data Collection (DCDC) App Software NCT02337647 | University of Nebraska | N/A |
| Completed | Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept NCT02291887 | Associated Retinal Consultants, Michigan | — |
| Unknown | Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patie NCT02296567 | East Florida Eye Institute | Phase 2 / Phase 3 |
| Unknown | Reticular Pseudodrusen Progression Study NCT02345317 | University Hospital Muenster | — |
| Completed | Single or Combined Protocols for NV-AMD NCT03552770 | University Hospital of Ferrara | Phase 4 |
| Completed | Sildenafil for Treatment of Choroidal Ischemia NCT04356716 | Columbia University | Phase 2 |
| Completed | VITAL - Individualising Therapy for Neovascular AMD With Aflibercept NCT02441816 | Moorfields Eye Hospital NHS Foundation Trust | Phase 4 |
| Completed | A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Inter NCT02314299 | Stealth BioTherapeutics Inc. | Phase 1 / Phase 2 |
| Unknown | Geographic Atrophy and Intravitreal Ranibizumab Injections NCT02372916 | University Health Network, Toronto | — |
| Completed | Colour Contrast Sensitivity for the Early Detection of Wet Age-related Macular Degereration (CEDAR) NCT02173496 | Aston University | — |
| Completed | Sparing of the Fovea in Geographic Atrophy Progression NCT02332343 | University Hospital, Bonn | — |
| Completed | Effect of a Self-care Intervention on Depression in People With Age-related Macular Degeneration or Diabetic R NCT02261194 | Maisonneuve-Rosemont Hospital | N/A |
| Completed | Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration NCT02140151 | Southern California Desert Retina Consultants, MC | Phase 1 / Phase 2 |
| Completed | Intravitreal Injections of Ziv-aflibercept for Macular Diseases NCT02556723 | Retina Clinic, Sao Paulo, Brazil | N/A |
| Terminated | Study of Retinal Findings in People With Signs and Symptoms of Alzheimer s Disease Enrolled in 09-M-0198 NCT02226835 | National Eye Institute (NEI) | — |